Učitavanje...
Secukinumab for Psoriasis in Obese Patients: Minireview and Clinical Experience
Psoriasis (PsO) has been associated with obesity, and its severity increases in obese subjects. The link between psoriatic condition and obesity is based on shared pathophysiological pathways where local and systemic inflammation promote each other; PsO is an inflammatory, immune-mediated disease, a...
Spremljeno u:
| Izdano u: | Case Rep Dermatol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
S. Karger AG
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816128/ https://ncbi.nlm.nih.gov/pubmed/31662736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000501990 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|